Literature DB >> 1936052

The clinician and the thyroid.

H J Biersack1, A Hotze.   

Abstract

The goiter prevalence in iodine-deficient regions is up to 25%-54%. The most frequent disease in these endemic areas is non-toxic goiter, which is, however, oftentimes connected with autonomously functioning thyroid tissue leading to borderline or overt hyperthyroidism. Other thyroid diseases like cancer, thyroiditis and hypothyroidism play only a minor role in a thyroid clinic, while cases of Graves' disease may be observed more frequently. The most cost-effective tools to evaluate thyroid patients are the hand, ear and mouth of the thyroid clinician. The differential diagnosis of thyroid disorders may be evaluated by a battery of diagnostic tools like in-vitro tests and high performance imaging modalities. Once the diagnosis is established, the appropriate therapeutic procedures (drugs, radioiodine, surgery) have to be chosen. This review should be considered as a guideline for the diagnosis and treatment of thyroid diseases. In addition, special problems concerning elderly patients and pregnant women are discussed, including the differential diagnosis of thyroid diseases.

Entities:  

Mesh:

Year:  1991        PMID: 1936052     DOI: 10.1007/bf00956719

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  72 in total

1.  Mechanism of the heparin-induced increase in the concentration of free thyroxine in plasma.

Authors:  C M Mendel; P H Frost; S T Kunitake; R R Cavalieri
Journal:  J Clin Endocrinol Metab       Date:  1987-12       Impact factor: 5.958

2.  Replacement dosage of L-thyroxine in hypothyroidism. A re-evaluation.

Authors:  J M Stock; M I Surks; J H Oppenheimer
Journal:  N Engl J Med       Date:  1974-03-07       Impact factor: 91.245

3.  99mTc-pertechnetate for measuring thyroid suppressibility.

Authors:  J Shimmins; W D Alexander; D G McLarty; J W Robertson; D J Sloane
Journal:  J Nucl Med       Date:  1971-02       Impact factor: 10.057

4.  The determination of thyroid volume by ultrasound and its relationship to body weight, age, and sex in normal subjects.

Authors:  L Hegedüs; H Perrild; L R Poulsen; J R Andersen; B Holm; P Schnohr; G Jensen; J M Hansen
Journal:  J Clin Endocrinol Metab       Date:  1983-02       Impact factor: 5.958

5.  Heparin in vivo effect on free thyroxin.

Authors:  P Lundberg; R Jagenburg; G Lindstedt; E Nyström
Journal:  Clin Chem       Date:  1982-05       Impact factor: 8.327

6.  How to deal with undetectable and low measurable serum thyroglobulin levels in the follow-up of patients with differentiated thyroid carcinoma?

Authors:  M Välimäki; B A Lamberg
Journal:  Acta Endocrinol (Copenh)       Date:  1985-12

7.  Total and free thyroid hormone concentrations in patients receiving maintenance replacement treatment with thyroxine.

Authors:  C J Pearce; R L Himsworth
Journal:  Br Med J (Clin Res Ed)       Date:  1984-03-03

8.  Diagnostic performance of sensitive measurements of serum thyrotropin during severe nonthyroidal illness: their role in the diagnosis of hyperthyroidism.

Authors:  M F Bayer; J A Macoviak; I R McDougall
Journal:  Clin Chem       Date:  1987-12       Impact factor: 8.327

9.  Thyroid failure in the elderly. Microsomal antibodies as discriminant for therapy.

Authors:  M J Rosenthal; W C Hunt; P J Garry; J S Goodwin
Journal:  JAMA       Date:  1987-07-10       Impact factor: 56.272

10.  [Therapy of endemic goiter with levothyroxine and iodide. A multicenter study].

Authors:  P Pfannenstiel
Journal:  Dtsch Med Wochenschr       Date:  1988-03-04       Impact factor: 0.628

View more
  3 in total

Review 1.  An update on diagnostic methods in the investigation of diseases of the thyroid.

Authors:  M J Reinhardt; E Moser
Journal:  Eur J Nucl Med       Date:  1996-05

2.  Hyperthyroidism of Graves' disease: evidence for only unilateral involvement of the thyroid gland in a 31-year-old female patient.

Authors:  H P Dimai; S Ramschak-Schwarzer; S Lax; R W Lipp; G Leb
Journal:  J Endocrinol Invest       Date:  1999-03       Impact factor: 4.256

3.  Fluorine-18 fluorodeoxyglucose positron emission tomography in the follow-up of differentiated thyroid cancer.

Authors:  F Grünwald; A Schomburg; H Bender; E Klemm; C Menzel; T Bultmann; H Palmedo; J Ruhlmann; B Kozak; H J Biersack
Journal:  Eur J Nucl Med       Date:  1996-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.